TPG Capital has reached a first close of its two China funds, having received commitments of RMB4 billion ($635 million). The private equity firm said that 90% of the capital raised came from private investors rather than government-linked entities. It wants private capital to account for 50% of total commitments to the funds.
Both funds launched in August 2010 and are joint venture partnerships with local governments. The TPG Shanghai RMB Fund is backed by the Shanghai municipal government and Pudong New Area government and...
A unit of China Zhongwang has agreed to buy US aluminum company Aleris Corporation in a deal worth $2.3 billion, facilitating an exit for majority owner Oaktree Capital Management.
Beijing Allcure Medical Technology, a Chinese medical start-up that develops cloud-based radiotherapy technology, has raised an extended Series A round of funding worth RMB180 million ($27 million).
Sequoia India and US-based Sands Capital Ventures have led a $27.4 million Series B round of funding for Mitra Biotech, an India and US-based company that focuses on personalized cancer therapies.